807 related articles for article (PubMed ID: 32997322)
1. COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine.
Guan W; Lan W; Zhang J; Zhao S; Ou J; Wu X; Yan Y; Wu J; Zhang Q
Virol Sin; 2020 Dec; 35(6):685-698. PubMed ID: 32997322
[TBL] [Abstract][Full Text] [Related]
2. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
Wang D; Li Z; Liu Y
J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak.
Maciorowski D; Ogaugwu C; Durvasula SR; Durvasula R; Kunamneni A
SLAS Discov; 2021 Mar; 26(3):311-329. PubMed ID: 33319627
[TBL] [Abstract][Full Text] [Related]
4. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for COVID-19: The reality and challenges.
Jean SS; Lee PI; Hsueh PR
J Microbiol Immunol Infect; 2020 Jun; 53(3):436-443. PubMed ID: 32307245
[TBL] [Abstract][Full Text] [Related]
6. COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review.
Raj CTD; Kandaswamy DK; Danduga RCSR; Rajasabapathy R; James RA
Arch Microbiol; 2021 Jul; 203(5):2043-2057. PubMed ID: 33555378
[TBL] [Abstract][Full Text] [Related]
7. Treatment of SARS-CoV-2: How far have we reached?
Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
[TBL] [Abstract][Full Text] [Related]
8. Emerging treatment strategies for COVID-19 infection.
Gavriatopoulou M; Ntanasis-Stathopoulos I; Korompoki E; Fotiou D; Migkou M; Tzanninis IG; Psaltopoulou T; Kastritis E; Terpos E; Dimopoulos MA
Clin Exp Med; 2021 May; 21(2):167-179. PubMed ID: 33128197
[TBL] [Abstract][Full Text] [Related]
9. Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options.
Sreekanth Reddy O; Lai WF
Chembiochem; 2021 Mar; 22(6):939-948. PubMed ID: 33031623
[TBL] [Abstract][Full Text] [Related]
10. Possible treatment and strategies for COVID-19: review and assessment.
Trivedi N; Verma A; Kumar D
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
[TBL] [Abstract][Full Text] [Related]
11. Psychopharmacology of COVID-19.
Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir.
Negru PA; Radu AF; Vesa CM; Behl T; Abdel-Daim MM; Nechifor AC; Endres L; Stoicescu M; Pasca B; Tit DM; Bungau SG
Biomed Pharmacother; 2022 Mar; 147():112700. PubMed ID: 35131656
[TBL] [Abstract][Full Text] [Related]
13. Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
Miller-Handley H; Luckett K; Govil A
Adv Chronic Kidney Dis; 2020 Sep; 27(5):434-441. PubMed ID: 33308510
[TBL] [Abstract][Full Text] [Related]
14. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Martinez MA
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
Bokharee N; Khan YH; Khokhar A; Mallhi TH; Alotaibi NH; Rasheed M
Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1219-1244. PubMed ID: 33719819
[No Abstract] [Full Text] [Related]
16. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
17. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
[TBL] [Abstract][Full Text] [Related]
18. Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia in a Newborn Treated With Remdesivir and Coronavirus Disease 2019 Convalescent Plasma.
Hopwood AJ; Jordan-Villegas A; Gutierrez LD; Cowart MC; Vega-Montalvo W; Cheung WL; McMahan MJ; Gomez MR; Laham FR
J Pediatric Infect Dis Soc; 2021 May; 10(5):691-694. PubMed ID: 33306130
[TBL] [Abstract][Full Text] [Related]
19. Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Yadav AK; Wen S; Xu X; Yu L
Ann Palliat Med; 2021 Jan; 10(1):707-720. PubMed ID: 33440983
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in treatment of Coronavirus Disease-2019.
Ambrosino I; Barbagelata E; Corbi G; Ciarambino T; Politi C; Moretti AM
Monaldi Arch Chest Dis; 2020 Dec; 90(4):. PubMed ID: 33305554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]